What are monoclonal antibodies?

Monoclonal antibody (mAb) medications are laboratory-made proteins that work in your body by attaching to parts of the virus and helping your immune system respond more quickly to fight it.

Monoclonal antibodies (mAb) may minimize the potential for higher risk patients to progress to severe disease and/or hospitalization.

Who may be eligible to receive a monoclonal antibody medication?

  • Your COVID-19 test comes back positive
  • You are not hospitalized
  • You have had mild to moderate symptoms that started less than 7 days ago
  • You are at high risk of progressing to severe infection

A different medication is available for people who are extremely immunocompromised (for example have had an organ transplant, are on active chemotherapy, etc.) but have not been exposed to COVID.

If you believe that you would be an appropriate candidate for these therapies, then please contact your medical provider to see if an infusion/injection is right for you.

If you do not have a medical provider, view available treatment sites to find the nearest place that may be able to discuss this option and may treat you. 

Monoclonal antibodies should not be considered the standard of care for the treatment of all patients with COVID-19.

For frequently asked questions on monoclonal antibodies infusion, please see Monoclonal Antibody Treatment